These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8736792

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Distribution of dystrophin and dystrophin-associated protein 43DAG (beta-dystroglycan) in the central nervous system of normal controls and patients with Duchenne muscular dystrophy.
    Uchino M, Hara A, Mizuno Y, Fujiki M, Nakamura T, Tokunaga M, Hirano T, Yamashita T, Uyama E, Ando Y, Mita S, Ando M.
    Intern Med; 1996 Mar; 35(3):189-94. PubMed ID: 8785451
    [Abstract] [Full Text] [Related]

  • 3. Altered distribution of beta-dystroglycan in sarcolemma of human dystrophic muscles: an immunohistochemical study.
    Jimi T, Wakayama Y, Takeda A, Kobayashi T, Kumagai T, Suzuki Y, Hasegawa O, Yamashita S, Shibuya S, Kuroiwa Y.
    Muscle Nerve; 1995 Aug; 18(8):910-3. PubMed ID: 7630355
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Introduction to muscular dystrophy.
    Porter JD.
    Microsc Res Tech; 1995 Aug; 48(3-4):127-30. PubMed ID: 10679960
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dystrophin, utrophin and beta-dystroglycan expression in skeletal muscle from patients with Becker muscular dystrophy.
    Kawajiri M, Mitsui T, Kawai H, Kobunai T, Tsuchihashi T, Saito S.
    J Neuropathol Exp Neurol; 1996 Aug; 55(8):896-903. PubMed ID: 8759779
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice.
    Jayasinha V, Nguyen HH, Xia B, Kammesheidt A, Hoyte K, Martin PT.
    Neuromuscul Disord; 2003 Jun; 13(5):365-75. PubMed ID: 12798792
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A cysteine 3340 substitution in the dystroglycan-binding domain of dystrophin associated with Duchenne muscular dystrophy, mental retardation and absence of the ERG b-wave.
    Lenk U, Oexle K, Voit T, Ancker U, Hellner KA, Speer A, Hübner C.
    Hum Mol Genet; 1996 Jul; 5(7):973-5. PubMed ID: 8817332
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
    Crosbie RH, Barresi R, Campbell KP.
    FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
    [Abstract] [Full Text] [Related]

  • 13. Ultrastructural localization of adhalin in normal murine skeletal myofiber.
    Wakayama Y, Inoue M, Murahashi M, Shibuya S, Jimi T, Kojima H, Oniki H.
    Ann Neurol; 1996 Feb; 39(2):217-23. PubMed ID: 8967753
    [Abstract] [Full Text] [Related]

  • 14. Immunogold localization of adhalin, alpha-dystroglycan and laminin in normal and dystrophic skeletal muscle.
    Cullen MJ, Walsh J, Roberds SL, Campbell KP.
    Biochem Soc Trans; 1996 May; 24(2):274S. PubMed ID: 8736932
    [No Abstract] [Full Text] [Related]

  • 15. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
    Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, Arahata K.
    Neurology; 2001 Jul 10; 57(1):115-21. PubMed ID: 11445638
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.
    Martin PT.
    Glycobiology; 2003 Aug 10; 13(8):55R-66R. PubMed ID: 12736199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.